View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Capmatinib 400, Non-Small Cell Lung Cancer
Protocol-ID: 1793 V1.0 (Mini), CAPM400, NSCLCIndication(s)
- Lung Carcinoma, Non-Small Cell (METex14 skipping mutation, MET Amplification); ICD-10 C34.-
Links
- Prescribing information for Capmatinib (TABRECTA) (FDA) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 04.06.2021